FROVA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Frova, and when can generic versions of Frova launch?
Frova is a drug marketed by Endo Pharms, Amneal Pharms Co, Glenmark Pharms Ltd, Mylan, and Renata. and is included in five NDAs.
The generic ingredient in FROVA is frovatriptan succinate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the frovatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Frova
A generic version of FROVA was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.
Summary for FROVA
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Patent Applications: | 2,355 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for FROVA |
What excipients (inactive ingredients) are in FROVA? | FROVA excipients list |
DailyMed Link: | FROVA at DailyMed |
Pharmacology for FROVA
Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for FROVA
Paragraph IV (Patent) Challenges for FROVA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FROVA | Tablets | frovatriptan succinate | 2.5 mg | 021006 | 1 | 2011-03-09 |
US Patents and Regulatory Information for FROVA
Expired US Patents for FROVA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Endo Pharms | FROVA | frovatriptan succinate | TABLET;ORAL | 021006-001 | Nov 8, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FROVA
See the table below for patents covering FROVA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Slovakia | 131993 | AGONISTS 5 HT-1 RECEPTORS | ⤷ Try a Trial |
Japan | H06508827 | ⤷ Try a Trial | |
Japan | 3364222 | ⤷ Try a Trial | |
United Kingdom | 9113802 | ⤷ Try a Trial | |
Japan | H08504790 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for FROVA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0591280 | C00591280/01 | Switzerland | ⤷ Try a Trial | FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH |
0591280 | SPC/GB03/014 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 3 METHYLAMINO-6-CARBOXAMIDO-1, 2, 3, 4-TETRAHYDROCARBAZOLE ("FROVATRIPTAN") INCLUDING A SALT, SOLVATE OR HYDRATE THEREOF; REGISTERED: FR NL 24548 20001212; UK PL 16239/0017 20021007; UK PL 16239/0018 20021007 |
0591280 | 37/2002 | Austria | ⤷ Try a Trial | PRODUCT NAME: FROVATRIPAN; NAT. REGISTRATION NO/DATE: 1-24487 20020424; FIRST REGISTRATION: FR NL 24548 20001212 |
0591280 | 01C0019 | France | ⤷ Try a Trial | PRODUCT NAME: FROVATRIPTAN SUCCINATE MONOHYDRATE; NAT. REGISTRATION NO/DATE: NL 24548 20001212; FIRST REGISTRATION: FR - NL 24548 20001212 |
0591280 | C300103 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FROVATRIPTAN EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 27211RVG 27212 2002190419; FIRST REGISTRATION: NL 24548 20001212 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |